Robert Baffi, SVP, Technical Operations at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 10,300 shares at $31.91 ($329K) on 2008-07-30, disclosed to the SEC on 2008-08-01.
Scheduled sale ($329k) by SVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.91 | 700 | $22K | 6.8% |
| 2 | $31.92 | 500 | $16K | 4.8% |
| 3 | $31.93 | 300 | $10K | 2.9% |
| 4 | $31.94 | 1,300 | $42K | 12.6% |
| 5 | $31.94 | 700 | $22K | 6.8% |
| 6 | $31.95 | 321 |
| $10K |
| 3.1% |
| 7 | $31.96 | 879 | $28K | 8.5% |
| 8 | $31.97 | 700 | $22K | 6.8% |
| 9 | $31.97 | 200 | $6K | 1.9% |
| 10 | $31.98 | 1,900 | $61K | 18.4% |
| 11 | $31.99 | 100 | $3K | 1.0% |
| 12 | $32.00 | 600 | $19K | 5.8% |
| 13 | $32.09 | 2,100 | $67K | 20.5% |
| Total | $31.98 avg | 10,300 | $329K | 100% |
| Filing → |
| BMRN | SELL | 2017-10-02 | $2.0M | — | Filing → |
| BMRN | SELL | 2016-05-19 | $435K | — | Filing → |
| BMRN | SELL | 2015-03-05 | $1.6M | — | Filing → |